References

Anderson, Keaven M. 2007. “Optimal Spending Functions for Asymmetric Group Sequential Designs.” Biometrical Journal 49 (3): 337–45.

Anderson, Keaven M., and Jason B. Clark. 2010. “Fitting Spending Functions.” Statistics in Medicine 29 (3): 321–27.

Bauer, Peter, and F. Kohne. 1994. “Evaluation of Experiments with Adaptive Interim Analyses.” Biometrics 50 (4): 1029–41.

Center for Drug Evaluation and Research. 2008. “Guidance for Industry on Diabetes Mellitus-Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes.” United States Department of Health and Human Services, Food and Drug Administration. https://www.federalregister.gov/d/E8-30086.

Cui, Lu, HM James Hung, and Sue-Jane Wang. 1999. “Modifications of Sample Size in Group Sequential Clinical Trials.” Biometrics 55 (3): 853–57.

Cytel, Inc. 2007. EAST 5. Cambridge, MA: Cytel, Inc.

Farrington, Conor P, and Godfrey Manning. 1990. “Test Statistics and Sample Size Formulae for Comparative Binomial Trials with Null Hypothesis of Non-Zero Risk Difference or Non-Unity Relative Risk.” Statistics in Medicine 9 (12): 1447–54.

Gordon, Ian, and Ray Watson. 1985. “The Myth of Continuity-Corrected Sample Size Formulae.” Biometrics 52 (1): 71–76.

Hwang, Irving K, Weichung J Shih, and John S De Cani. 1990. “Group Sequential Designs Using a Family of Type 1 Error Probability Spending Functions.” Statistics in Medicine 9 (12): 1439–45.

Jennison, Christopher, and Bruce W. Turnbull. 2000. Group Sequential Methods with Applications to Clinical Trials. Boca Raton, FL: Chapman; Hall/CRC.

Kim, Kyungmann, and David L Demets. 1987. “Design and Analysis of Group Sequential Tests Based on Type I Error Spending Rate Functions.” Biometrika 74 (1): 149–54.

Lachin, John M., and Mary A. Foulkes. 1986. “Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-up, Noncompliance, and Stratification.” Biometrics 42 (3): 507–19.

Lan, K K Gordon, and David L DeMets. 1983. “Discrete Sequential Boundaries for Clinical Trials.” Biometrika 70 (3): 659–63.

Liu, Qing, and George YH Chi. 2001. “On Sample Size and Inference for Two-Stage Adaptive Designs.” Biometrics 57 (1): 172–77.

Madsen, Richard W, and Kenneth B Fairbanks. 1983. “P Values for Multistage and Sequential Tests.” Technometrics 25 (3): 285–93.

Miettinen, Ollie, and Markku Nurminen. 1985. “Comparative Analysis of Two Rates.” Statistics in Medicine 4 (2): 213–26.

Müller, Hans-Helge, and Helmut Schäfer. 2001. “Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches.” Biometrics 57 (3): 886–91.

O’Brien, Peter C, and Thomas R Fleming. 1979. “A Multiple Testing Procedure for Clinical Trials.” Biometrika 35 (3): 549–56.

Pampallona, Sandro, and Anastasios A Tsiatis. 1994. “Group Sequential Trials for One-Sided and Two-Sided Hypothesis Testing with Provision for Early Stopping in Favor of the Null Hypothesis.” Journal of Statistical Planning and Inference 42 (1-2): 19–35.

Pocock, Stuart J. 1977. “Group Sequential Methods in the Design and Analysis of Clinical Trials.” Biometrika 64 (2): 191–99.

Proschan, Michael A, and Sally A Hunsberger. 1995. “Designed Extension of Studies Based on Conditional Power.” Biometrics 51 (4): 1315–24.

Proschan, Michael A., K K Gordon Lan, and Janet Turk Wittes. 2006. Statistical Monitoring of Clinical Trials. A Unified Approach. New York, NY: Springer.

Scharfstein, Daniel O, Anastasios A Tsiatis, and James M Robins. 1997. “Semiparametric Efficiency and Its Implication on the Design and Analysis of Group-Sequential Studies.” Journal of the American Statistical Association 92 (440): 1342–50.

Sellke, Thomas, and David Siegmund. 1983. “Sequential Analysis of the Proportional Hazards Model.” Biometrika 70 (2): 315–26.

Slud, Eric, and LJ Wei. 1982. “Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic.” Journal of the American Statistical Association 77 (380): 862–68.

The CAPTURE Investigators. 1997. “Randomised Placebo-Controlled Trial of Abciximab Before and During Coronary Intervention in Refractory Unstable Angina: The CAPTURE Study.” The Lancet 349 (9063): 1429–35.

The GUSTO V Investigators. 2001. “Reperfusion Therapy for Acute Myocardial Infarction with Fibrinolytic Therapy or Combination Reduced Fibrinolytic Therapy and Platelet Glycoprotein IIb/IIIa Inhibition: The GUSTO V Randomised Trial.” The Lancet 357 (9272): 1905–14.

Tsiatis, Anastasios A. 1982. “Repeated Significance Testing for a General Class of Statistics Use in Censored Survival Analysis.” Journal of the American Statistical Association 77 (380): 855–61.

Wang, Samuel K, and Anastasios A Tsiatis. 1987. “Approximately Optimal One-Parameter Boundaries for Group Sequential Trials.” Biometrics 43 (1): 193–99.